-
One Clearwater woman says caring for her wife with Alzheimer's disease wouldn't be possible without help from a "tribe" of friends and community services.
-
Families can get blindsided by risky behavior with money, sometimes even before a diagnosis. Having tough conversations and setting up guardrails in advance can help prevent disaster.
-
Lessons learned in a Mayo Clinic study could lead to treatment or even a cure for Alzheimer's.
-
The AHEAD Study - with participants in the Orlando region - examines whether the newly approved drug lecanemab can prevent or at least delay the appearance of Alzheimer's symptoms.
-
Scientists are digging into why a few people escape the rarest form of Alzheimer's, which is inherited and strikes young.
-
Facilitator Pamela Levin of the Alzheimer's Association said Art Connects ALZ is a relaxing program using watercolors . It's therapeutic but not art therapy or art instruction.
-
The FDA approved the use of Leqembi in January for patients with mild or early cases of dementia tied to Alzheimer’s. A year’s treatment runs about $26,500, and there are few options outside of self-pay.
-
The woman was unresponsive, and nurses were unable to detect her breathing. A state agency report found the facility "failed to ensure residents received dignified treatment and care at end of life."
-
The FDA overruled its own scientific advisers in approving Aduhelm, despite lack of proof that it met its promise of slowing patients' decline.
-
Sarasota's Roskamp Institute was the first to discover a protein that tends to form clumps in the brains of people with Alzheimer's. A new drug has been shown to reduce it.